Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
•To evaluate the safety of multiple IV doses of MCMV5322A/MCMV3068A given to cytomegalovirus (CMV) seronegative recipients of a renal transplant from a CMV seropositive donor. •To determine the clinical activity of multiple IV doses of MCMV5322A/MCMV3068A given to CMV-seronegative recipients of a renal transplant from a CMV-seropositive donor.
Critère d'inclusion
- Transplant-associated cytomegalovirus (CMV) infection